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1. Introduction 
The lectin of Limulus polyphemus haemolymph 
agglutinates rythrocytes [l-4] and other cells [ 51. 
Neuraminic acid has been shown to be the specific 
ligand of this lectin. The lectin has been isolated by 
ultracentrifugation a d preparative starch gel electro- 
phoresis [6], by DEAE-Sephadex and gel filtration 
chromatography [7] and by ultracentrifugation, 
affinity and gel filtration chromatography [8]. Though 
the protein prepared by the last two methods [7,8] 
was homogeneous with respect o molecular weight, 
polyacrylamide gel electrophoresis and immunoelectro- 
phoresis, we got three fractions by affinity chromato- 
graphy. The first two fractions (Limulin I and II) did 
not agglutinate erythrocytes, but the third fraction 
(Limulin III) was very active. We wish to report the 
affinity chromatography purification of Limulin 
III and to show that Limulin binds O-glycosides 
of N-acyl-neuraminic a ids more strongly than free 
N-acryl-neuraminic a ids. 
2. Materials and methods 
N-acetyl-neuraminic a id, N-glycolyl-neuraminic 
and bovine submaxillary mucin (BSM) were obtained 
from Sigma; 2-O-methyl N-acetyl_P-neuraminic acid 
has been obtained by N-acetylation [9] of 2-O-methyl- 
fl-neuraminic acid which has been prepared according 
to Schauer and Buschcr [lo] ; 2-O-methyl N-acetyl- 
a-neuraminic acid has been prepared according to 
Meindl and Tuppy [ 111. N-acyl-cu-neuraminidyl acid 
2+6 N-acetyl-D-galactosaminitol hasbeen isolated by 
treatment of BSM with alkaline sodium borohydride 
[ 123 followed by chromatography on Dowex 2X8 
[ 131. Chromogens derivatives of N-acyl-cu-neuraminidyl 
acid-2+6&acetylgalactosamine (sialyl chromogens 
I and III) [ 141 have been isolated by alkaline treat- 
ment of BSM, chromatography on Dowex 2X8, 
chromatography on charcoal-celite mixture (elution 
with 50 p. 100 aqueous ethanol). 
The following submaxillary mucins were used: PSM 
(porcine) containing 90 p. 100 of N-glycolyl-neur- 
aminic acid [ 151, ESM (equine) containing mainly 
4-O-acetyl N-acetyl-neuraminic a id, BSM (bovine) 
containing predominantly 90acetyl N-acyl-neur- 
aminic acid [16,17]‘with 15 p.100 ofN-glycolyl 
and 85 p. 100 of N-acetyl [ 181, and OSM (ovine) 
containing iV-acetyl-neuraminic acid [ 191. 
Sephadex G 50 (fine), DEAE-Sephadex A 50 and 
Sepharose 4 B were obtained from Pharmacia Fine 
Chemicals, Uppsala, Sweden; Ultrogel AcA 22 from 
L.K.B., Sweden: Dowex 2X8 from Serva, Heidelberg. 
Frozen haemolymph from L. polyphemus was 
obtained from the Marine Biological Laboratory, 
Woods Hole, Mass. (U.S.A.). 
2.1. Analysis of sugar 
Purity of sugars and disaccharides or their derivatives 
was checked by paper electrophoresis on Whatman 3
(10 V/cm, 4 h in pyridine acetic acid water 3/2/400, 
v/v, pH 5.4) and by paper chromatography on 
Whatman 1(n-butanol/pyridine/HCl 0.1 N, 5/3/2, 
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v/v). Sialic acids were detected with the orcinol 
reagent [20] , neutral sugars with the anilineoxalate 
reagent [21] . 
Total N-acyl-neuraminic a ids were determined by 
the method of Aminoff [22] after hydrolysis of the 
sample with 0.05 M Hz SO!, @O”C, 60 min) or by 
the method of Bial [23] . N-acetyl hexosamines were 
determined by the method of Lewy and McAllan 
[24] . Chromogen derivatives ofN-acetyl-osamine 
were determined by the same method, but without 
heating after the addition of the alkaline reagent. N- 
acetyl-neuraminic a id and N-acetyl-galactosamine 
were used as standards. 
2.2. Affiniv chromatogmphy column 
Sepharose 4 B (40 ml) activated with cyanogen 
bromide [25] was coupled with bovine submaxillary 
mucin (200 mg) and then with 2.amino 2.hydroxy- 
methyl-propane 1,3 diol(lO0 mg) in order to block 
any unreacted activated groups. The substituted 
Sepharose was washed with a 0.1 M NaCl, 0.01 M 
CaCls , 0.05 M Tris-HCl buffer (pH 8.5) and poured 
into a column (2.5 X 13 cm). After acidic hydrolysis 
[22] (80°C, HsS04 0.05 M, 1 h) it was found that 
500 E.cg of siahc acid per ml of substituted Sepharose 
was released. The amount of bound mucin can then 
be evaluated at 2.5 mg per ml of substituted Sepharose. 
3. Results and discussion 
3.1. Rtrijkation of haemagglu tinating limulin 
The first purification steps were done as previously 
described [7]. At the last step an affinity chromato- 
graphy was used instead of gel filtration chromato- 
graphy. The active material obtained after the 
chromatography on DEAE Sephadex column was 
applied directly (without concentration or dialysis) 
onto the column of BSM-substituted Sepharose quili- 
brated with 0.1 M NaCl, 0.01 M CaClz ,0.05 M 
Tris-HCl buffer, pH 8.5. A large part of material 
passed through the column and was devoid of ag- 
glutinating activtiy (Limulin I). In preliminary experi- 
ments, the column was then washed stepwise, 
increasing the ionic strength (NaCl, 0.2 M to 1 M). 
Various amounts of proteins were eluted at each step, 
but no agglutinating activity could be detected. In 
routine experiments, the column was washed with 
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the higher ionic strength buffer (1 .O M NaCl, 0.01 M 
CaCls ,0.05 M TrisHCl, pH 8.5). Under these 
conditions, the eluted protein (Limulin II) was 
devoid of agglutinating activity. However, when 
agglutination tests were done with Limulin I or 
Limulin II in presence of MnCls 0.1 M instead of 
CaCls 0.1 M, a slight agglutinating activity was 
detected; the lower protein concentration required 
to agglutinate horse red blood cells was about 
100 jig/ml. 
The active protein (Limulin III) was eluted with 
a calcium-free buffer 1 .O M NaCl, 0.05 M Tris-HCl, 
pH 8.5. In order to test the effectiveness of this 
purification procedure, the protein (11 mg) purified 
according to Oppenheim et al. [8] was applied onto 
the column: A minor fraction (1 mg) was not retard- 
ed, a large fraction (9 mg) was eluted with 1 .O M 
NaCl, calcium-containing buffer, and the active 
protein (1 mg) was eluted with the calcium-free 
buffer. Fractions containing Limulin III were pooled 
and dialyzed against 0.1 M NaCI, 0.01 M CaCls 0.05 
M Tris-HCl, pH 8.5. 
The purification procedure is summarized in Table 
1 and the affinity chromatography step is shown in 
fig.1. By this procedure, the purification factor 
(33 000) is much higher than that obtained previously 
1700 [8] 60 [7] and 20 [6]. The yield of active 
material is almost quantitative, and the amount of 
Limulin III obtained from 1000 ml of crude haemo- 
lymph is about 4 mg. The lower concentration required 
to agglutinate horse red blood’cells is about 2 ng/ml. 
Limulin III gave one band when passed through an 
ultrogel AcA 22 column (1.5 X 100 cm), and the 
agglutinating activity followed strictly the protein 
concentration. The sedimentation constant of Limulin 
III is s”m, ,+. 13.9, as previously described for Limulin 
[7] . Polyacrylamide gel electrophoresis in presence 
of sodium dodecylsulfate 0.1 p. 100 and mercapto- 
ethanol 0.1 p. 100 leads to a molecular weight identical 
to that found previously [7]. 
3.2. Specific inhibition of a&u tina ting activity 
The inhibition experiments were done as we have 
already described [7]. The results are summarized in
Table 2. Free N-acetyl-neuraminic a id and free N- 
glycolyl neuraminic acid, which are known to be 
mainly /3-anomers [26] , inhibit the agglutination at 
the same high concentration (200 mM), therefore 
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0.05MTris HCI pH 8.5 
0.1 M NaCl 
0.01 M CaC12 
1 M NaCl 1M NaCl 
0.01 M CaC12 _ 
200 300 400 500 
Elution Volume ( ml) 
800 700 
Fig.1. Purification of Limulus polyphemus hemagglutinin by affinity chromatography on mucin-sepharose column (2.5 X 13 cm) 
equilibrated in 0.05 M Tris-HCl, 0.01 M CaCl, , 0.1 M NaCl buffer, pH 8.5. Pooled active fractions from DEAE-Sephadex chromato- 
graphy column were applied. The proteins were eluted with Tris, CaCI, , 0.1 M NaCl buffer (Limulin I), with Tris, CaC12, 1 M NaCl 
buffer (Limulin II) and then with Tris, 1 M NaCl buffer (Limulin III). 10 ml fractions were collected (Limulin I) and thereafter 3 
ml were collected (Limulin II and III). -, absorbance at 280 nm; -, macroscopic agglutination with 3% horse erythrocytes 
in 0.1 M NaCl, 0.1 M CaCl,. 
Table 2 
Inhibition of agglutinating activity 
Compounds Concentration* 
(10’ X mol/l) 
Specificity** 
factor 
N-Acetyl-neuraminic acid 
N-Glycolyl-neuraminic a&id 
2-GMethyl p-neuraminic acid 
2-GMethyl N-acetyl &neuraminic acid 
2-GMethyl N-ace@ wneuraminic acid 
N-Acyl-orneuraminy12-6 chromogens 
N-Acyl-a-neuraminyl 2-+6 N-acetyl- 
galactosaminitol 
ESM 
OSM 
BSM 
PSM 
200 
200 
*** 
20 
10 
5 
0.04 5000 
0.3 650 
0.1 2000 
0.03 6000 
0.03 6000 
1 
1 
_ 
10 
20 
40 
* Concentration of inhibitors, expressed as sialic acid, needed to inhibit one unit of 
agglutination. 
** Relativb to the activity of free N-acetyl-neuraminic acid. 
*** No inhibition with a 300 mM concentration. 
248 
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the N-glycolyl group does not change the capability 
of binding to the Limulin. 2.O-methyl f -neuraminic 
acid, with a free amino-group, has no effect at alI, 
so the amido-group seems to be important for the 
binding. The low molecular weight glycosides derivat- 
ives of N-acyl-neuraminic a id inhibit the agglutination 
at a lower concentration than free N-acyl-neuraminic 
acid. The fl-anomer of 2-@methyl ZV-acetyl-neuraminic 
acid is slightly less active than the cuanomer. 
The concentration of BSM and PSM required to 
inhibit agglutination islow and in the same range 
for these two mucins (30 PM). ESM is less active 
(300 PM) and OSM has an intermediary activity 
(100 PM). Therefore, the 0acetyl in position 4 as in 
ESM seems to lower the affinity; the 0-acetyl in 
position 9 as in BSM or the N-glycolyl as in PSM 
seems to increase slightly the affinity, while there 
is no difference between free N-glycolyl- and N-acetyl- 
neuraminic acid. A strong inhibitory effect is obtained 
with the disaccharide derivatives released from BSM. 
The dissacharide derivatives obtained by alkaline 
treatment in the absence of sodium borohydride are 
forty times more active than free sialic acid and the 
disaccharide r leased by alkaline treatment in the 
presence of sodium borohydride inhibitis agghrtina- 
tion in the same concentration range as BSM. 
Therefore, the inhibitory effect is not related to the 
macromolecular structure of mucin but to its N-acyl- 
neuraminic ontaining disaccharide. 
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